Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)

Phase 1

Completed

Conditions: Acute Myeloid Leukemia
AML
Myelodysplastic Disorders

Interventions: Drug: Idarubicin
Drug: Sorafenib
Drug: Ara-C

First Posted Date: 2007-10-12

Last Posted Date: 2018-08-23

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 78

Registration Number: NCT00542971

Locations: 🇺🇸
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States

Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Procedure: Paravertebral Block
Drug: Propofol
Drug: Ropivacaine
Drug: Fentanyl
Drug: Midazolam

First Posted Date: 2007-10-11

Last Posted Date: 2015-04-13

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 89

Registration Number: NCT00542542

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Home-Based Measures of Physical Activity and Body Composition

Not Applicable

Active, not recruiting

Conditions: Cardiovascular Disease

Interventions: Behavioral: Environmental Assessments
Behavioral: Physical Activity Recall

First Posted Date: 2007-10-11

Last Posted Date: 2025-01-10

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 62

Registration Number: NCT00542438

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Not Applicable

Active, not recruiting

Conditions: Tobacco Use Disorder
Fanconi Anemia
Premalignant Lesion
Oral Cavity and Lip Precancerous Condition
Erythroplakia
Lichen Planus
Oral Cavity Leukoplakia
Oral Neoplasm

Interventions: Other: Cytology Specimen Collection Procedure
Procedure: Diagnostic Microscopy
Procedure: Diagnostic Procedure
Procedure: Fluorescence Imaging
Procedure: Fluorescence Spectroscopy

First Posted Date: 2007-10-11

Last Posted Date: 2025-04-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 338

Registration Number: NCT00542373

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma

Withdrawn

Conditions: Mantle Cell Lymphoma
Lymphoma

Interventions: Procedure: PET/CT Scanning

First Posted Date: 2007-10-10

Last Posted Date: 2012-12-06

Lead Sponsor: M.D. Anderson Cancer Center

Registration Number: NCT00541424

A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy

Completed

Conditions: Breast Cancer

Interventions: Procedure: NAC Sparing Mastectomy
Behavioral: Questionnaire

First Posted Date: 2007-10-04

Last Posted Date: 2013-08-26

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 37

Registration Number: NCT00539227

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma

Phase 2

Terminated

Conditions: Neuroblastoma

Interventions: Drug: Carboplatin
Drug: Etoposide
Drug: Melphalan
Procedure: Stem Cell Infusion
Device: ClinicMACS

First Posted Date: 2007-10-04

Last Posted Date: 2019-07-26

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 3

Registration Number: NCT00539500

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Not Applicable

Recruiting

Conditions: Ovarian Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-10-04

Last Posted Date: 2025-04-10

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 8000

Registration Number: NCT00539162

Locations: 🇺🇸
Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine, Miami, Florida, United States
🇺🇸
John Stoddard Cancer Center, Des Moines, Iowa, United States
🇺🇸
Carol G. Simon Cancer Center / Atlantic Health, Morristown, New Jersey, United States

and more 8 locations

Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)

Phase 1

Completed

Conditions: Hyperparathyroidism

Interventions: Drug: Vitamin D
Device: Four-dimensional computed tomography (4DCT)

First Posted Date: 2007-10-03

Last Posted Date: 2019-03-25

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 22

Registration Number: NCT00538720

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

OraTest in Combination With Visual Examination and Visual Examination Alone

Phase 3

Terminated

Conditions: Head And Neck Cancer
Oropharynx Cancer

Interventions: Other: Visual Examination
Drug: OraTest

First Posted Date: 2007-09-28

Last Posted Date: 2016-05-13

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1

Registration Number: NCT00537199

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy